Immune checkpoint blockade therapy in head and neck cancer: a review

• Prif Awduron: Shajedul Islam (Awdur), Md Shahed Rafi Pavel (Awdur), Syed Taufiqul Islam (Awdur), Nazmus Shalehin (Awdur), Shahed Jahan Babu (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Update Dental College, 2018-12-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Head and neck cancer (HNC) is a common malignant tumor, carrying a poor prognosis, and despite advances in oncology, this rate has not improved significantly for decades. It has recently been evaluated that the immunologic checkpoint inhibitors become a novel promising strategic immunotherapy in the...